drugset / Trial / NCT00130390
Study of Nitazoxanide Tablets in the Treatment of Mild to Moderate Active Crohn's Disease
RandomizedCrossoverQuadruple-blindTreatment
Summary
The primary objective of this study is to evaluate the efficacy and safety of nitazoxanide compared to a placebo in reducing the signs and symptoms of mild to moderate active Crohn's disease in adults.
Timeline
- Start
- 2005-08
- Primary completion
- 2007-12
- Completion
- 2008-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nitazoxanide | Other / unclassified | 500 mg | Oral |